Top Markets
#1 Siren Siren +34.47%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.54%
#3 Ribbita by Virtuals Ribbita by Virtuals +21.29%
#4 PulseChain PulseChain +18.23%
#5 Bitway Bitway +17.71%
#6 Cysic Cysic +17.67%
#7 KUB Coin KUB Coin +16.88%
#8 Wiki Cat Wiki Cat +16.30%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.06%
#10 The Grays Currency The Grays Currency +15.85%
Coin of the day
Siren Siren
設定
言語
日本
通貨
USD
テーマ
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
株式のランク #31164
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
株価
$0.3902
時価総額
$13.79M
変化（1日）
-13.48%
変化（1年）
-68.78%
国
IL
取引 NeuroSense Therapeutics Ltd. (NRSN)

カテゴリー

Healthcare
NeuroSense Therapeutics Ltd.（NRSN）の収益
Aug 2026 時点の収益 TTM: 0
NeuroSense Therapeutics Ltd. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
NeuroSense Therapeutics Ltd. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE